The home systolic BP also significantly decreased ( p = 0.03)
These include: Eating smaller meals this is a common recommendation for everyone with acid reflux and GERD

When labs are ordered in GLP-1 treatment, providers typically look at markers that help evaluate metabolic function, organ health, and potential risk factors: A1C and fasting glucose: to assess baseline glycemic control [2] Kidney function: to monitor dehydration risk and fluid balance, which GLP-1-related gastrointestinal side effects can affect [3] Liver enzymes: to ensure safe medication clearance and dosing [4] Lipid panel: to track key cardiometabolic markers that often shift with weight loss [5] Thyroid panel: to rule out thyroid disorders that can contribute to weight changes or mimic weight-related symptoms [6] Complete blood count and electrolytes: to check for underlying health issues or imbalances that could complicate early treatment [7] Important: Because Peak Wellness relies primarily on intake-based evaluation, patients with known medical conditions or incomplete health histories may want to discuss whether additional testing would be beneficial before starting treatment

Finally, the development of dual GLP-1/GLP-2 receptor agonists, such as dapiglutide, has shown promise in reducing intestinal transit time and increasing villus height in murine models, representing an exciting future strategy (117)
Support for Metabolism : Micro-dosing GLP-1s can help prevent the metabolic slowdown that often accompanies significant weight loss, supporting better energy balance and fat burning